Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-21

Clinical Trial Update: Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 2 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for an evidence-based stimulation protocol using recombinant FSH (rFSH) in infertility, completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • rFSH (recombinant follitropin alfa or other recombinant FSH product as applicable) (recombinant FSH)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Infertility | Phase 3 | Status: COMPLETED | Results posted: 2018-09-21